Coca-Cola (KO)

Coca-Cola is a classic example of a recession-resistant business. Whether the economy is booming or struggling, a can of Coke is affordable for most people.

The company’s entrenched market position, massive scale, and portfolio of iconic brands — including names like Sprite, Fresca, Dasani and Smartwater — give it plenty of pricing power.

Add solid geographic diversification — its products are sold in more than 200 countries and territories around the globe — and it’s clear that Coca-Cola can thrive through thick and thin. After all, the company went public more than 100 years ago.

More impressively, Coca-Cola has increased its dividend for 60 consecutive years. The stock currently yields 2.8%.

UBS analyst Peter Grom has a ‘buy’ rating on Coca-Cola and a price target of $68 — roughly 9% above where the stock sits today.

Fine wine is a sweet comfort in any situation — and now it can make your investment portfolio a little more comfortable, too. Now a platform called Vinovest helps everyday buyers invest in fine wines — no sommelier certification required.

Invest Now

Johnson & Johnson (JNJ)

When it comes to delivering recession-proof returns, few companies have done a better job than healthcare giant Johnson & Johnson.

The stock has been trending up for decades and for good reason. Johnson & Johnson’s business grows consistently through economic cycles.

Many of the company’s consumer health brands — such as Tylenol, Band-Aid, and Listerine — are household names. In total, JNJ has 29 products each capable of generating over $1 billion in annual sales.

Over the past 20 years, Johnson & Johnson’s adjusted EPS has increased at a steady pace of 8% annually.

And that means shareholders can look forward to higher dividends every year.

JNJ announced its 60th consecutive annual dividend increase in April and now offers an annual dividend yield of 2.6%

Raymond James analyst Jayson Bedford has an ‘outperform’ rating on JNJ and a price target of $185 — around 5% above the current levels.

Procter & Gamble (PG)

Procter & Gamble has an even longer dividend growth track record than Coca-Cola and Johnson & Johnson: the company has raised its payout to shareholders for 66 consecutive years.

That streak is a testament to its entrenched position in the consumer staples market. P&G has a portfolio of trusted brands like Bounty paper towels, Crest toothpaste, Gillette razor blades and Tide detergent.

These are products that households buy on a regular basis, regardless of what the economy is doing. As a result, the company can deliver reliable dividends even in tough times.

The latest dividend hike was announced in April, when the board of directors approved a 5% increase to the quarterly payout to 91.33 cents per share. The stock currently yields 2.5%.

Jefferies analyst Kevin Grundy has a ‘buy’ rating on Procter & Gamble and recently raised his price target from $149 to $164. That implies a potential upside of 12%.

Get a piece of commercial real estate

Enhance your portfolio with high-return commercial real estate

First National Realty Partners is the #1 option for accredited investors seeking superior risk-adjusted returns in the grocery-anchored necessity-based retail space.

While commercial real estate has always been reserved for a few elite investors, outperforming the S&P 500 over a 25-year period, First National Realty Partners allows you to access institutional-quality commercial real estate investments — without the leg work of finding deals yourself.

Invest with First National Realty Partners now.

About the Author

Jing Pan

Jing Pan

Investment Reporter

Jing is an investment reporter for MoneyWise. He is an avid advocate of investing for passive income. Despite the ups and downs he’s been through with the markets, Jing believes that you can generate a steadily increasing income stream by investing in high quality companies.

What to Read Next

Disclaimer

The content provided on MoneyWise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.